American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
By M. Kris, P. Hesketh, M. Somerfield, P. Feyer, R. Clark-Snow, J. Koeller, G. Morrow, L. Chinnery, Maurice Chesney, R. Gralla and 1 more. Journal of Clinical Oncology, 2006
707 citations recorded by the source corpus.
Subfields: Pediatrics, Perinatology and Child Health, Surgery
View Paper: https://www.semanticscholar.org/paper/8c1744d64ebdd5b25c4f63f79b10e030d6798394
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Polymorphism of human cytochrome P450 enzymes and its clinical impact (2009, background): “The three-drug combination of a 5-HT 3 receptor antagonist, dexamethasone, and aprepitant is highly recommended before chemotherapy of high emetic risk (Kris et al., 2006).”